CRESPONSE

Serial Number 90170301
606

Registration Progress

Application Filed
Sep 10, 2020
Under Examination
Jun 8, 2021
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered

Trademark Image

CRESPONSE

Basic Information

Serial Number
90170301
Filing Date
September 10, 2020
Published for Opposition
April 13, 2021
Abandonment Date
July 15, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 15, 2024
Classes
005 042

Rights Holder

Curesponse Ltd.

99
Address
6 Weitzman Street
Tel Aviv Medical Center (TAMC)
Tel Aviv 6423906
IL

Ownership History

Curesponse Ltd.

Original Applicant
99
Tel Aviv IL

Curesponse Ltd.

Owner at Publication
99
Tel Aviv IL

Legal Representation

Attorney
Abigail Rubinstein

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Jul 15, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 15, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 29, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 17, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 18, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
May 18, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 17, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 18, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 18, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
May 18, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 14, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 14, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 5, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 4, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 4, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 4, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 4, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 8, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 24, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 24, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 24, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 21, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 19, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 14, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic testing materials, namely, specialized tissue culture medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use; biological tissue cultures for medical purposes
Class 042
Laboratory testing in the nature of analysis in the field of cancer testing and pathology; medical laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation; providing testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes

Classification

International Classes
005 042